Antibodies against endogenous retroviruses promote lung cancer immunotherapy.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
04 2023
Historique:
received: 07 03 2022
accepted: 30 01 2023
medline: 21 4 2023
pubmed: 13 4 2023
entrez: 12 4 2023
Statut: ppublish

Résumé

B cells are frequently found in the margins of solid tumours as organized follicles in ectopic lymphoid organs called tertiary lymphoid structures (TLS)

Identifiants

pubmed: 37046094
doi: 10.1038/s41586-023-05771-9
pii: 10.1038/s41586-023-05771-9
pmc: PMC10115647
doi:

Substances chimiques

Hras protein, mouse EC 3.6.5.2
Cxcl13 protein, mouse 0
Antibodies 0

Banques de données

ClinicalTrials.gov
['NCT01888601']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

563-573

Subventions

Organisme : Cancer Research UK
ID : CTRNBC-2022/100001
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V033077/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 29911
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 21999
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 24956
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 17786
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 29569
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 30025
Pays : United Kingdom

Investigateurs

Andrew Rowan (A)
Ariana Huebner (A)
Brittany B Campbell (BB)
Chris Bailey (C)
Claudia Lee (C)
Dhruva Biswas (D)
Emma Colliver (E)
Foteini Athanasopoulou (F)
Haoran Zhai (H)
Jayant K Rane (JK)
Kristiana Grigoriadis (K)
Michelle Dietzen (M)
Michelle Leung (M)
Mihaela Angelova (M)
Olivia Lucas (O)
Othman Al-Sawaf (O)
Rachel Rosenthal (R)
Jerome Nicod (J)
Abigail Bunkum (A)
Antonia Toncheva (A)
Christopher Abbosh (C)
Corentin Richard (C)
Cristina Naceur-Lombardelli (C)
Francisco Gimeno-Valiente (F)
Jie Min Lam (JM)
Kerstin Thol (K)
Krupa Thakkar (K)
Mariana Werner Sunderland (M)
Martin D Forster (MD)
Nnennaya Kanu (N)
Paulina Prymas (P)
Robert Bentham (R)
Sadegh Saghafinia (S)
Sergio A Quezada (SA)
Sharon Vanloo (S)
Simone Zaccaria (S)
Siow Ming Lee (SM)
Sonya Hessey (S)
Wing Kin Liu (WK)
Dionysis Papadatos-Pastos (D)
James Wilson (J)
Sarah Benafif (S)
Tanya Ahmad (T)
Elaine Borg (E)
Mary Falzon (M)
Reena Khiroya (R)
Teresa Marafioti (T)
Abigail Sharp (A)
Camilla Pilotti (C)
Harjot Kaur Dhanda (HK)
Kitty Chan (K)
Nicole Gower (N)
Rachel Leslie (R)
Sean Smith (S)
Andrew G Nicholson (AG)
Eric Lim (E)
Javier Herrero (J)
Carla Castignani (C)
Elizabeth Larose Cadieux (E)
Jonas Demeulemeester (J)
Peter Van Loo (P)
Karl S Peggs (KS)
Catarina Veiga (C)
Gary Royle (G)
Charles-Antoine Collins-Fekete (CA)
Alexander James Procter (AJ)
Arjun Nair (A)
Asia Ahmed (A)
Magali N Taylor (MN)
Neal Navani (N)
Ricky M Thakrar (RM)
David Lawrence (D)
Davide Patrini (D)
Emma Nye (E)
Richard Kevin Stone (RK)
David Chuter (D)
Mairead MacKenzie (M)
Francesco Fraioli (F)
Paul Ashford (P)
Sam M Janes (SM)
Miljana Tanić (M)
Stephan Beck (S)
Alexandra Rice (A)
Anand Devaraj (A)
Chiara Proli (C)
Daniel Kaniu (D)
Harshil Bhayani (H)
Hema Chavan (H)
Hilgardt Raubenheimer (H)
Lyn Ambrose (L)
Mpho Malima (M)
Nadia Fernandes (N)
Paulo De Sousa (P)
Pratibha Shah (P)
Sarah Booth (S)
Silviu I Buderi (SI)
Simon Jordan (S)
Sofina Begum (S)
Ekaterini Boleti (E)
Aengus Stewart (A)
Alastair Magness (A)
Clare E Weeden (CE)
Dina Levi (D)
Eva Grönroos (E)
Jacki Goldman (J)
Mickael Escudero (M)
Philip Hobson (P)
Roberto Vendramin (R)
Stefan Boeing (S)
Tamara Denner (T)
Vittorio Barbè (V)
Wei-Ting Lu (WT)
William Hill (W)
Yutaka Naito (Y)
Zoe Ramsden (Z)
Anca Grapa (A)
Hanyun Zhang (H)
Khalid AbdulJabbar (K)
Xiaoxi Pan (X)
Kayleigh Gilbert (K)
Angeliki Karamani (A)
Benny Chain (B)
David R Pearce (DR)
Despoina Karagianni (D)
Elena Hoxha (E)
Felip Gálvez-Cancino (F)
Georgia Stavrou (G)
Gerasimos Mastrokalos (G)
Helen L Lowe (HL)
Ignacio Matos (I)
James L Reading (JL)
John A Hartley (JA)
Kayalvizhi Selvaraju (K)
Kezhong Chen (K)
Leah Ensell (L)
Mansi Shah (M)
Marcos Vasquez (M)
Maria Litovchenko (M)
Olga Chervova (O)
Piotr Pawlik (P)
Robert E Hynds (RE)
Saioa López (S)
Samuel Gamble (S)
Seng Kuong Anakin Ung (SKA)
Supreet Kaur Bola (SK)
Thanos P Mourikis (TP)
Victoria Spanswick (V)
Yin Wu (Y)
Emilie Martinoni Hoogenboom (E)
Fleur Monk (F)
James W Holding (JW)
Junaid Choudhary (J)
Kunal Bhakhri (K)
Marco Scarci (M)
Martin Hayward (M)
Nikolaos Panagiotopoulos (N)
Pat Gorman (P)
Robert C M Stephens (RCM)
Steve Bandula (S)
Yien Ning Sophia Wong (YNS)
Tristan Clark (T)
Heather Cheyne (H)
Mohammed Khalil (M)
Shirley Richardson (S)
Tracey Cruickshank (T)
Babu Naidu (B)
Gurdeep Matharu (G)
Jacqui A Shaw (JA)
Joan Riley (J)
Lindsay Primrose (L)
John Le Quesne (J)
Kevin G Blyth (KG)
Alastair Kerr (A)
Alexandra Clipson (A)
Anshuman Chaturvedi (A)
Caroline Dive (C)
Dominic G Rothwell (DG)
Elaine Kilgour (E)
Jonathan Tugwood (J)
Lynsey Priest (L)
Pedro Oliveira (P)
Philip Crosbie (P)
Gillian Price (G)
Judith Cave (J)
Keith M Kerr (KM)
Colin R Lindsay (CR)
Fiona H Blackhall (FH)
Matthew G Krebs (MG)
Yvonne Summers (Y)
Alan Kirk (A)
Mathew Thomas (M)
Mo Asif (M)
Nikos Kostoulas (N)
Rocco Bilancia (R)
Gary Middleton (G)
Michael J Shackcloth (MJ)
Angela Leek (A)
Jack Davies Hodgkinson (JD)
Nicola Totten (N)
Craig Dick (C)
Lily Robinson (L)
Peter Russell (P)
Madeleine Hewish (M)
Sarah Danson (S)
Jason F Lester (JF)
Fabio Gomes (F)
Kate Brown (K)
Mathew Carter (M)
Akshay J Patel (AJ)
Aya Osman (A)
Christer Lacson (C)
Gerald Langman (G)
Helen Shackleford (H)
Madava Djearaman (M)
Salma Kadiri (S)
Aiman Alzetani (A)
Jennifer Richards (J)
Lydia Scarlett (L)
Papawadee Ingram (P)
Serena Chee (S)
Silvia Austin (S)
Amrita Bajaj (A)
Apostolos Nakas (A)
Azmina Sodha-Ramdeen (A)
Dean A Fennell (DA)
Keng Ang (K)
Mohamad Tufail (M)
Mohammed Fiyaz Chowdhry (MF)
Molly Scotland (M)
Rebecca Boyles (R)
Sridhar Rathinam (S)
Claire Wilson (C)
Domenic Marrone (D)
Sean Dulloo (S)
Angeles Montero (A)
Elaine Smith (E)
Eustace Fontaine (E)
Felice Granato (F)
Helen Doran (H)
Juliette Novasio (J)
Kendadai Rammohan (K)
Leena Joseph (L)
Paul Bishop (P)
Rajesh Shah (R)
Stuart Moss (S)
Vijay Joshi (V)
Hugo J W L Aerts (HJWL)
Tom L Kaufmann (TL)
Roland F Schwarz (RF)
Judit Kisistok (J)
Mateo Sokac (M)
Miklos Diossy (M)
Zoltan Szallasi (Z)
Krijn Dijkstra (K)
Yinyin Yuan (Y)
Fiona Byrne (F)
Laura Amanda Boos (LA)
Benjamin Shum (B)
Camille L Gerard (CL)
Andreas M Schmitt (AM)
Christina Messiou (C)
David Cunningham (D)
Ian Chau (I)
Naureen Starling (N)
Nicholas Turner (N)
Liam Welsh (L)
Robin L Jones (RL)
Joanne Droney (J)
Susana Banerjee (S)
Kate C Tatham (KC)
Shaman Jhanji (S)
Kevin Harrington (K)
Alicia Okines (A)
Alison Reid (A)
Kate Young (K)
Andrew J S Furness (AJS)
Lisa Pickering (L)
Emma Nicholson (E)
Sacheen Kumar (S)
Katalin A Wilkinson (KA)
Anthony Swerdlow (A)
Robert J Wilkinson (RJ)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023. The Author(s).

Références

Schumacher, T. N. & Thommen, D. S. Tertiary lymphoid structures in cancer. Science 375, eabf9419 (2022).
pubmed: 34990248 doi: 10.1126/science.abf9419
Laumont, C. M., Banville, A. C., Gilardi, M., Hollern, D. P. & Nelson, B. H. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nat. Rev. Cancer 22, 414–430 (2022).
pubmed: 35393541 pmcid: 9678336 doi: 10.1038/s41568-022-00466-1
Boumelha, J. et al. An immunogenic model of KRAS-mutant lung cancer enables evaluation of targeted therapy and immunotherapy combinations. Cancer Res. 82, 3435–3448 (2022).
pubmed: 35930804 pmcid: 7613674 doi: 10.1158/0008-5472.CAN-22-0325
Hellmann, M. D. et al. Nivolumab plus ipilimumab in advanced non-small-cell lung cancer. N. Engl. J. Med. 381, 2020–2031 (2019).
pubmed: 31562796 doi: 10.1056/NEJMoa1910231
Patil, N. S. et al. Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer. Cancer Cell 40, 289–300 (2022).
pubmed: 35216676 doi: 10.1016/j.ccell.2022.02.002
Hao, D. et al. The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinoma. Cancer Discov. 12, 2626–2645 (2022).
pubmed: 36098652 doi: 10.1158/2159-8290.CD-21-1658
Mesin, L., Ersching, J. & Victora, G. D. Germinal center B cell dynamics. Immunity 45, 471–482 (2016).
pubmed: 27653600 pmcid: 5123673 doi: 10.1016/j.immuni.2016.09.001
Litchfield, K. et al. Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition. Cell 184, 596–614 (2021).
pubmed: 33508232 pmcid: 7933824 doi: 10.1016/j.cell.2021.01.002
Leader, A. M. et al. Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification. Cancer Cell 39, 1594–1609 (2021).
pubmed: 34767762 pmcid: 8728963 doi: 10.1016/j.ccell.2021.10.009
Zhang, Y. et al. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. Cancer Cell 39, 1578–1593 (2021).
pubmed: 34653365 doi: 10.1016/j.ccell.2021.09.010
Preuss, K. D., Zwick, C., Bormann, C., Neumann, F. & Pfreundschuh, M. Analysis of the B-cell repertoire against antigens expressed by human neoplasms. Immunol. Rev. 188, 43–50 (2002).
pubmed: 12445280 doi: 10.1034/j.1600-065X.2002.18805.x
Kassiotis, G. & Stoye, J. P. Immune responses to endogenous retroelements: taking the bad with the good. Nat. Rev. Immunol. 16, 207–219 (2016).
pubmed: 27026073 doi: 10.1038/nri.2016.27
Li, M., Huang, X., Zhu, Z. & Gorelik, E. Sequence and insertion sites of murine melanoma-associated retrovirus. J. Virol. 73, 9178–9186 (1999).
pubmed: 10516025 pmcid: 112951 doi: 10.1128/JVI.73.11.9178-9186.1999
Pothlichet, J., Mangeney, M. & Heidmann, T. Mobility and integration sites of a murine C57BL/6 melanoma endogenous retrovirus involved in tumor progression in vivo. Int. J. Cancer 119, 1869–1877 (2006).
pubmed: 16708391 doi: 10.1002/ijc.22066
Ottina, E. et al. Restoration of endogenous retrovirus infectivity impacts mouse cancer models. Cancer Immunol. Res. 6, 1292–1300 (2018).
pubmed: 30143537 pmcid: 6485373 doi: 10.1158/2326-6066.CIR-18-0038
Dieu-Nosjean, M. C. et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J. Clin. Oncol. 26, 4410–4417 (2008).
pubmed: 18802153 doi: 10.1200/JCO.2007.15.0284
Germain, C. et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am. J. Respir. Crit. Care Med. 189, 832–844 (2014).
pubmed: 24484236 doi: 10.1164/rccm.201309-1611OC
Vanhersecke, L. et al. Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression. Nat. Cancer 2, 794–802 (2021).
pubmed: 35118423 pmcid: 8809887 doi: 10.1038/s43018-021-00232-6
Panova, V., Attig, J., Young, G. R., Stoye, J. P. & Kassiotis, G. Antibody-induced internalisation of retroviral envelope glycoproteins is a signal initiation event. PLoS Pathog. 16, e1008605 (2020).
pubmed: 32453763 pmcid: 7274472 doi: 10.1371/journal.ppat.1008605
Young, G. R. et al. Resurrection of endogenous retroviruses in antibody-deficient mice. Nature 491, 774–778 (2012).
pubmed: 23103862 pmcid: 3511586 doi: 10.1038/nature11599
Shi, J. et al. PD-1 controls follicular T helper cell positioning and function. Immunity 49, 264–274 (2018).
pubmed: 30076099 pmcid: 6104813 doi: 10.1016/j.immuni.2018.06.012
Good-Jacobson, K. L. et al. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat. Immunol. 11, 535–542 (2010).
pubmed: 20453843 pmcid: 2874069 doi: 10.1038/ni.1877
Skoulidis, F. et al. Sotorasib for lung cancers with KRAS p.G12C mutation. N. Engl. J. Med. 384, 2371–2381 (2021).
pubmed: 34096690 pmcid: 9116274 doi: 10.1056/NEJMoa2103695
Rowland, S. L., DePersis, C. L., Torres, R. M. & Pelanda, R. Ras activation of Erk restores impaired tonic BCR signaling and rescues immature B cell differentiation. J. Exp. Med. 207, 607–621 (2010).
pubmed: 20176802 pmcid: 2839140 doi: 10.1084/jem.20091673
Denton, A. E. et al. Type I interferon induces CXCL13 to support ectopic germinal center formation. J. Exp. Med. 216, 621–637 (2019).
pubmed: 30723095 pmcid: 6400543 doi: 10.1084/jem.20181216
Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782–795 (2013).
pubmed: 24138885 doi: 10.1016/j.immuni.2013.10.003
Ukita, M. et al. CXCL13-producing CD4
pubmed: 35552285 pmcid: 9309049 doi: 10.1172/jci.insight.157215
Kasperek, A. et al. Therapeutic potential of the human endogenous retroviral envelope protein HEMO: a pan-cancer analysis. Mol. Oncol. 16, 1451–1473 (2021).
Deakin, C. T. et al. Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases. Med 2, 1093–1109 (2021).
pubmed: 34414384 doi: 10.1016/j.medj.2021.08.001
Fendler, A. et al. Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study. Nat. Cancer 2, 1321–1337 (2021).
Monde, K. et al. Movements of ancient human endogenous retroviruses detected in SOX2-expressing cells. J. Virol. 96, e0035622 (2022).
pubmed: 35420440 doi: 10.1128/jvi.00356-22
Watkins, T. B. K. et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature 587, 126–132 (2020).
pubmed: 32879494 pmcid: 7611706 doi: 10.1038/s41586-020-2698-6
Wang-Johanning, F. et al. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. J. Natl Cancer Inst. 104, 189–210 (2012).
pubmed: 22247020 pmcid: 3274512 doi: 10.1093/jnci/djr540
Park, S. et al. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as complementary biomarker for immune checkpoint inhibition in non-small-cell lung cancer. J. Clin. Oncol. 40, 1916–1928 (2022).
pubmed: 35271299 pmcid: 9177249 doi: 10.1200/JCO.21.02010
Hollern, D. P. et al. B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer. Cell 179, 1191–1206 (2019).
pubmed: 31730857 pmcid: 6911685 doi: 10.1016/j.cell.2019.10.028
Herati, R. S. et al. PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine. Nat. Immunol. 23, 1183–1192 (2022).
pubmed: 35902637 pmcid: 9880663 doi: 10.1038/s41590-022-01274-3
Song, I. H. et al. Predictive value of tertiary lymphoid structures assessed by high endothelial venule counts in the neoadjuvant setting of triple-negative breast cancer. Cancer Res. Treat. 49, 399–407 (2017).
pubmed: 27488875 doi: 10.4143/crt.2016.215
Lee, H. J. et al. Prognostic significance of tumor-infiltrating lymphocytes and the tertiary lymphoid Structures in HER2-positive breast cancer treated with adjuvant trastuzumab. Am. J. Clin. Pathol. 144, 278–288 (2015).
pubmed: 26185313 doi: 10.1309/AJCPIXUYDVZ0RZ3G
Sahin, U. et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl Acad. Sci. USA 92, 11810–11813 (1995).
pubmed: 8524854 pmcid: 40492 doi: 10.1073/pnas.92.25.11810
Leong, S. P. et al. Expression and modulation of a retrovirus-associated antigen by murine melanoma cells. Cancer Res. 48, 4954–4958 (1988).
pubmed: 2842042
Kassiotis, G. & Stoye, J. P. Making a virtue of necessity: the pleiotropic role of human endogenous retroviruses in cancer. Philos. Trans. R. Soc. Lond. B 372, 20160277 (2017).
doi: 10.1098/rstb.2016.0277
Wang-Johanning, F. et al. Expression of human endogenous retrovirus K envelope transcripts in human breast cancer. Clin. Cancer Res. 7, 1553–1560 (2001).
pubmed: 11410490
Parikh, A. R. et al. Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial. Nat. Cancer 2, 1124–1135 (2021).
pubmed: 35122060 pmcid: 8809884 doi: 10.1038/s43018-021-00269-7
Tokuyama, M. et al. Antibodies against human endogenous retrovirus K102 envelope activate neutrophils in systemic lupus erythematosus. J. Exp. Med. 218, e20191766 (2021).
pubmed: 34019642 pmcid: 8144942 doi: 10.1084/jem.20191766
Dogan, I. et al. Multiple layers of B cell memory with different effector functions. Nat. Immunol. 10, 1292–1299 (2009).
pubmed: 19855380 doi: 10.1038/ni.1814
Casola, S. et al. Tracking germinal center B cells expressing germ-line immunoglobulin γ1 transcripts by conditional gene targeting. Proc. Natl Acad. Sci. USA 103, 7396 (2006).
pubmed: 16651521 pmcid: 1464351 doi: 10.1073/pnas.0602353103
Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001).
pubmed: 11299042 pmcid: 31338 doi: 10.1186/1471-213X-1-4
Snippert, H. J. et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143, 134–144 (2010).
pubmed: 20887898 doi: 10.1016/j.cell.2010.09.016
Hanke, K. et al. Reconstitution of the ancestral glycoprotein of human endogenous retrovirus K and modulation of its functional activity by truncation of the cytoplasmic domain. J. Virol. 83, 12790–12800 (2009).
pubmed: 19812154 pmcid: 2786854 doi: 10.1128/JVI.01368-09
Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).
pubmed: 29203879 pmcid: 5715110 doi: 10.1038/s41598-017-17204-5
Messal, H. A. et al. Antigen retrieval and clearing for whole-organ immunofluorescence by FLASH. Nat. Protoc. 16, 239–262 (2021).
pubmed: 33247285 doi: 10.1038/s41596-020-00414-z
Jamal-Hanjani, M. et al. Tracking the evolution of non-small-cell lung cancer. N. Engl. J. Med. 376, 2109–2121 (2017).
pubmed: 28445112 doi: 10.1056/NEJMoa1616288
Bailey, C. et al. Tracking cancer evolution through the disease course. Cancer Discov. 11, 916–932 (2021).
pubmed: 33811124 pmcid: 7611362 doi: 10.1158/2159-8290.CD-20-1559
Al Bakir, M. et al. The evolution of non-small cell lung cancer metastases in TRACERx. Nature https://doi.org/10.1038/s41586-023-05729-x (2023).
Frankell, A. M. et al. The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature https://doi.org/10.1038/s41586-023-05783-5 (2023).
Martínez-Ruiz, C. et al. Genomic–transcriptomic evolution in lung cancer and metastasis. Nature https://doi.org/10.1038/s41586-023-05706-4 (2023).
Rosenthal, R. et al. Neoantigen-directed immune escape in lung cancer evolution. Nature 567, 479–485 (2019).
pubmed: 30894752 pmcid: 6954100 doi: 10.1038/s41586-019-1032-7
Attig, J. et al. LTR retroelement expansion of the human cancer transcriptome and immunopeptidome revealed by de novo transcript assembly. Genome Res. 29, 1578–1590 (2019).
pubmed: 31537638 pmcid: 6771403 doi: 10.1101/gr.248922.119
Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417–419 (2017).
pubmed: 28263959 pmcid: 5600148 doi: 10.1038/nmeth.4197
Danaher, P. et al. Gene expression markers of tumor infiltrating leukocytes. J. Immunother. Cancer 5, 18 (2017).
pubmed: 28239471 pmcid: 5319024 doi: 10.1186/s40425-017-0215-8
Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218 (2016).
pubmed: 27765066 pmcid: 5073889 doi: 10.1186/s13059-016-1070-5
Cabrita, R. et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577, 561–565 (2020).
pubmed: 31942071 doi: 10.1038/s41586-019-1914-8
Song, L. et al. TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data. Nat. Methods 18, 627–630 (2021).
pubmed: 33986545 pmcid: 9328942 doi: 10.1038/s41592-021-01142-2
Jung, H. et al. DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load. Nat. Commun. 10, 4278 (2019).
pubmed: 31537801 pmcid: 6753140 doi: 10.1038/s41467-019-12159-9
Goldman, M. J. et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat. Biotechnol. 38, 675–678 (2020).
pubmed: 32444850 pmcid: 7386072 doi: 10.1038/s41587-020-0546-8

Auteurs

Kevin W Ng (KW)

Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.

Jesse Boumelha (J)

Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.

Katey S S Enfield (KSS)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Jorge Almagro (J)

Adult Stem Cell Laboratory, The Francis Crick Institute, London, UK.

Hongui Cha (H)

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Oriol Pich (O)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Takahiro Karasaki (T)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.

David A Moore (DA)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Department of Cellular Pathology, University College London Hospitals, London, UK.

Roberto Salgado (R)

Department of Pathology, ZAS Hospitals, Antwerp, Belgium.
Division of Research, Peter MacCallum Cancer Centre, Melbourne, Queensland, Australia.

Monica Sivakumar (M)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

George Young (G)

Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.
Bioinformatics and Biostatistics Facility, The Francis Crick Institute, London, UK.

Miriam Molina-Arcas (M)

Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.

Sophie de Carné Trécesson (S)

Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.

Panayiotis Anastasiou (P)

Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.

Annika Fendler (A)

Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.

Lewis Au (L)

Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
Renal and Skin Units, The Royal Marsden Hospital, London, UK.

Scott T C Shepherd (STC)

Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
Renal and Skin Units, The Royal Marsden Hospital, London, UK.

Carlos Martínez-Ruiz (C)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Clare Puttick (C)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

James R M Black (JRM)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Thomas B K Watkins (TBK)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Hyemin Kim (H)

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Seohee Shim (S)

Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.

Nikhil Faulkner (N)

Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.
National Heart and Lung Institute, Imperial College London, London, UK.

Jan Attig (J)

Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.

Selvaraju Veeriah (S)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Neil Magno (N)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Sophia Ward (S)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Advanced Sequencing Facility, The Francis Crick Institute, London, UK.

Alexander M Frankell (AM)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Maise Al Bakir (M)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Emilia L Lim (EL)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Mark S Hill (MS)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Gareth A Wilson (GA)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Daniel E Cook (DE)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Nicolai J Birkbak (NJ)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark.

Axel Behrens (A)

Adult Stem Cell Laboratory, The Francis Crick Institute, London, UK.
Cancer Stem Cell Laboratory, Institute of Cancer Research, London, UK.
Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
CRUK Convergence Science Centre, Imperial College, London, UK.

Nadia Yousaf (N)

Renal and Skin Units, The Royal Marsden Hospital, London, UK.
Lung Unit, The Royal Marsden Hospital, London, UK.

Sanjay Popat (S)

Lung Unit, The Royal Marsden Hospital, London, UK.
Division of Clinical Studies, The Institute of Cancer Research, London, UK.

Allan Hackshaw (A)

Cancer Research UK and University College London Cancer Trials Centre, London, UK.

Crispin T Hiley (CT)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Kevin Litchfield (K)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Tumour Immunogenomics and Immunosurveillance Laboratory, University College London Cancer Institute, London, UK.

Nicholas McGranahan (N)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Mariam Jamal-Hanjani (M)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.
Department of Oncology, University College London Hospitals, London, UK.

James Larkin (J)

Renal and Skin Units, The Royal Marsden Hospital, London, UK.
Melanoma and Kidney Cancer Team, The Institute of Cancer Research, London, UK.

Se-Hoon Lee (SH)

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.

Samra Turajlic (S)

Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
Renal and Skin Units, The Royal Marsden Hospital, London, UK.
Melanoma and Kidney Cancer Team, The Institute of Cancer Research, London, UK.

Charles Swanton (C)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.
Department of Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk.

Julian Downward (J)

Oncogene Biology Laboratory, The Francis Crick Institute, London, UK. julian.downward@crick.ac.uk.

George Kassiotis (G)

Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK. george.kassiotis@crick.ac.uk.
Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK. george.kassiotis@crick.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH